EMA Initiates Safety Review of Injectable Iron Medicines for Potential Bone Disorder Link

The European Medicines Agency's PRAC committee has begun a safety review of all injectable iron-containing medicines. This action follows concerns that these products may cause low blood phosphate levels and related bone problems like osteomalacia, even after minimal doses. The review will assess the effectiveness of current risk reduction measures and the overall safety profile.